Neoadjuvant Chemotherapy ( FOLFIRINOX or Gemcitabine With Nab‐Paclitaxel) for Borderline‐Resectable Pancreatic Cancer: Long‐Term Results of a Randomized Controlled Trial ( NUPAT ‐01)
Year: 2026
Type: article
Study design: Clinical Trial
DOI: 10.1002/jhbp.70150
Authors: Junpei Yamaguchi, Hideki Takami, Yukihiro Yokoyama, Tsutomu Fujii, Suguru Yamada, Hiroki Kawashima, Takuya Ishikawa, Osamu Maeda, Hiroshi Ogawa, Tomoki Ebata
Institutions: Nagoya University Hospital, University of Toyama
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166517244